Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.10 (0.44%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £234.54m
SCLP Live PriceLast checked at - London Stock Exchange

Intraday Scancell Holdings Share Chart

Director/PDMR Shareholding

22 Oct 2013 08:00

RNS Number : 0284R
Scancell Holdings Plc
22 October 2013
 



Scancell Holdings plc

("Scancell" or the "Company")

Director Share Dealing

The Company has been notified that on 21 October 2013 Lindy Durrant and Richard Goodfellow each sold 100,000 shares in the Company from their respective holdings held jointly with Scancell Employee Benefit Trust at a price of 30 pence per share.

Following these transactions their holdings in the Company are as follows:

 

Director Name

No. of shares held in own sole name post transaction

 

No. of shares held jointly with Scancell Employee Benefit Trust post transaction

 

Lindy Durrant

1,606,960

 

8,773,960

Richard Goodfellow

200,000

 

6,343,840

 

For Further Information:

 

Scancell Holdings Plc 

+ 44 (0) 20 7831 3113 

Dr Richard Goodfellow, Joint CEO 

Professor Lindy Durrant, Joint CEO 

Cenkos Securities plc:

+44 (0) 20 7397 8900

Camilla Hume

Stephen Keys

FTI Consulting

+44 (0) 20 7831 3113

Simon Conway

Mo Noonan

Dr. Reuter Investor Relations

+(0) 49 251 980 1561

Kim von Ahn

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAKEFAAADFFF
Date   Source Headline
2nd Nov 20205:00 pmRNSConvertible Loan Notes & Total Voting Rights
29th Oct 202010:15 amRNSResult of Open Offer and Adjournment of GM
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn
27th Oct 20204:36 pmRNSPrice Monitoring Extension
26th Oct 202010:10 amRNSConversion of Convertible Loan Notes
21st Oct 20204:12 pmRNSNotice of Annual General Meeting
16th Oct 20207:00 amRNSFinal Results for the year ended 30 April 2020
15th Oct 202011:10 amRNSHolding(s) in Company
14th Oct 202011:36 amRNSHolding(s) in Company
13th Oct 202012:07 pmRNSPosting of Circular
12th Oct 20207:00 amRNSProposed investment by Redmile and Open Offer
5th Oct 20207:00 amRNSNotice of Final Results
2nd Oct 20207:00 amRNSCollaboration to manufacture COVID-19 vaccine
24th Sep 20207:00 amRNSDirectorate Change
14th Sep 20204:41 pmRNSSecond Price Monitoring Extn
14th Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20209:05 amRNSSecond Price Monitoring Extn
14th Sep 20209:00 amRNSPrice Monitoring Extension
11th Sep 20204:41 pmRNSSecond Price Monitoring Extn
11th Sep 20204:35 pmRNSPrice Monitoring Extension
8th Sep 20204:40 pmRNSSecond Price Monitoring Extn
8th Sep 20204:35 pmRNSPrice Monitoring Extension
4th Sep 20207:00 amRNSDirector Award of Share Options
27th Aug 20207:00 amRNSFunds awarded by Innovate UK for COVID-19 vaccine
26th Aug 20204:02 pmRNSHolding(s) in Company
25th Aug 202010:11 amRNSHolding(s) in Company
12th Aug 20203:13 pmRNSHolding(s) in Company
12th Aug 202012:57 pmRNSDirector Dealing
11th Aug 202010:54 amRNSResults of General Meeting
23rd Jul 20204:44 pmRNSShareholder circular
22nd Jul 20201:51 pmRNSResult of Placing and Notice of General Meeting
22nd Jul 20207:00 amRNSProposed Capital Raise
24th Jun 20207:00 amRNSNew publication highlights potential of Modi-1
12th Jun 20209:30 amRNSPublication highlights potential of AvidiMab
1st May 20207:00 amRNSDirector salaries and award of share options
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:00 pmRNSPrice Monitoring Extension
28th Apr 202010:06 amRNSDirector Dealing
27th Apr 20204:39 pmRNSDirector Dealing
24th Apr 20202:05 pmRNSSecond Price Monitoring Extn
24th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSScancell: Development of vaccine against COVID-19
16th Mar 20204:42 pmRNSSecond Price Monitoring Extn
16th Mar 20204:38 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSScancell to Present at Three Research Conferences
3rd Feb 20207:00 amRNSSCIB1 IND Application Approved
31st Jan 20207:00 amRNSInterim Results
20th Jan 20207:00 amRNSThird agreement signed for antibody platform
17th Dec 201912:44 pmRNSDirector's Dealings
16th Dec 20197:00 amRNSSecond agreement signed for AvidiMab platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.